September 26, 2017

Mountain View, California

Digital Health

Transforming Drug Development

 

Translational Science Forum

Co-​organized by:

 

Program -​ Tuesday, September 26

7:00 AM

ARRIVAL

Registration and Breakfast

8:00 AM

WELCOMING REMARKS

Dr. Raffaella Faggioni, Senior Director, MedImmune

Dr. Rachael Callcut, Associate Professor of Surgery, UCSF

8:15 AM

MEDIMMUNE/ASTRAZENECA PRESENTATION
Digital Health to Benefit Patients

Dr. Bahija Jallal, Executive Vice President, Head of MedImmune

8:45 AM

OPENING KEYNOTE SPEECH

Capturing the Elusive Promise of Digital Health

Dr. David Shaywitz, Chief Medical Officer, DNAnexus

9:15 AM

KEYNOTE SPEECH
Pharma 3.0: Moving from Widgets to Digits

Dr. James Mault, Senior Vice President and Chief Medical Officer, Qualcomm Life

9:45 AM

KEYNOTE SPEECH
Revolutionizing Diagnostics and Drug Discovery with Machine Learning

Philip Nelson, Director of Engineering in Google Research, Google

10:15 AM

BREAK

10:35 AM

Session 1: CARDIOVASCULAR and METABOLIC DISEASES

Presentation with Q&A

Transforming Data into Insights and Actions in Cardiovascular and Metabolic Diseases using Digital Technologies

Introduction by Anand Subramony, Vice President, Novel Product Technologies, MedImmune
 
Smarter Sensors & Wearable Devices for Medicine

Dr. Sumita Pennathur, Associate Professor in Mechanical Engineering, UC Santa Barbara
 
Leveraging Biological Panomic Big Data and Artificial Intelligence to Disrupt Drug Development

Dr. Szilard Voros, Founder and CEO, Global Genomics Group

Deconstructing, Engineering, and Rewilding the Gut Microbiome

Dr. Justin Sonnenburg, Associate Professor in Microbiology and Immunology, Stanford University

Reformatting the Design Approach for Digital Medical Devices

Rajan Patel, Chief Executive Officer, iO Lifescience

12:20 PM

NETWORKING LUNCH

1:20 PM

COMPANY SHOWCASE/CHALLENGE
Please click here for details and to apply.

2:20 PM

Session 2: IMMUNO-​ONCOLOGY

Presentation with Q&A

Digital Technology: Can it make a difference in Immuno-​Oncology drug development?

Introduction by Philip “Zach” Brohawn, Associate Director, Diagnostic Expert, MedImmune

 

Comprehensive Genomic Profiling of Plasma and Immunotherapy Response Prediction

Dr. Justin Odegaard, Senior Medical Director and Laboratory Co-​Director, Guardant Health

 

Deep Learning Uncovering New Biomarkers in Circulating Nucleic Acids to Improve Patient Stratification for Immunotherapy Response Prediction

Riley Ennis, Co-​founder and COO, Freenome
 
Advancing Drug Development Using Artificial Intelligence and Computational Pathology

Dr. Andrew Beck, Co-​founder and CEO, PathAl
 
Tracking Human T Cell Responses to Cancer Immunotherapy

Dr. Lawrence Fong, Efim Guzik Distinguished Professor in Cancer Biology, UCSF

4:05 PM

BREAK

4:25 PM

KEYNOTE SPEECH

Technology meets Neuroscience -​ A Vision of the Future of Brain Optimization

Dr. Adam Gazzaley, Professor in Neurology, Founder and Executive Director at Neuroscape, UCSF

4:55 PM

WRAP UP REMARKS

Dr. Matt Bell, COO, MedImmune

5:10 PM

NETWORKING RECEPTION

 

© MedImmune 2017